Baxter Financial Statements
Baxter Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Baxter Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 11,263.0 | 10,378.0 | 9,849.0 |
| Gross Profit ($ mil.) | 5,519.0 | 4,737.0 | 4,093.0 |
| Operating Income ($ mil.) | 2,168.0 | 1,839.0 | 1,639.0 |
| Total Net Income ($ mil.) | 1,707.0 | 1,397.0 | 956.0 |
| Diluted EPS (Net Income) | 2.61 | 2.13 | 1.52 |
Baxter Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,189.0 | 2,877.0 | 3,009.0 |
| Gross Profit ($ mil.) | 1,627.0 | 1,380.0 | 1,485.0 |
| Operating Income ($ mil.) | 698.0 | 550.0 | 610.0 |
| Total Net Income ($ mil.) | 544.0 | 429.0 | 478.0 |
| Diluted EPS (Net Income) | 0.85 | 0.67 | 0.74 |
Baxter Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.70 | 2.19 | 1.56 |
| Price/Earnings Ratio | 23.86 | 22.29 | 15.82 |
| Price/Book Ratio | 6.06 | 2.28 | 1.52 |
| Price/Cash Flow Ratio | 17.92 | 15.76 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Baxter Financial Ratios
Baxter Competitive Intelligence
| Bayer HealthCare | Talecris | Wyeth | |
|---|---|---|---|
| Annual Sales ($ mil.) | 15,467.5 | 1,114.5 | 22,399.8 |
| Employees | 51,400 | 3,472 | 50,527 |
| Market Cap ($ mil.) | -- | -- | 57,110.9 |
Competitive Landscape






